Main Website
E-paper
Russia’s 'Sputnik-V' vaccine produced an antibody response in all the 76 participants in phase 1/2 trials. The so-called viral vector vaccine has now started a 40,000-strong phase 3 trial
Dhaka Tribune
Copyright Ⓒ 2012-2019. 2A Media Limited. All Rights Reserved.
8/C, FR Tower, Panthapath, Dhaka 1207, Bangladesh.
Kazi Anis Ahmed, Publisher
Leave a Comment